• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Analysts Are Updating Their Hera S.p.A. (BIT:HER) Estimates After Its Interim Results

    Simply Wall St·08/01/2026 08:24:58
    Listen to the news

    Hera S.p.A. (BIT:HER) shareholders are probably feeling a little disappointed, since its shares fell 3.4% to €3.79 in the week after its latest half-year results. Results overall were respectable, with statutory earnings of €0.32 per share roughly in line with what the analysts had forecast. Revenues of €6.5b came in 4.5% ahead of analyst predictions. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year.

    We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

    earnings-and-revenue-growth
    BIT:HER Earnings and Revenue Growth August 1st 2026

    Following last week's earnings report, Hera's five analysts are forecasting 2026 revenues to be €12.6b, approximately in line with the last 12 months. Statutory per-share earnings are expected to be €0.32, roughly flat on the last 12 months. Before this earnings report, the analysts had been forecasting revenues of €12.8b and earnings per share (EPS) of €0.31 in 2026. So it's pretty clear that, although the analysts have updated their estimates, there's been no major change in expectations for the business following the latest results.

    See our latest analysis for Hera

    There were no changes to revenue or earnings estimates or the price target of €4.54, suggesting that the company has met expectations in its recent result. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. The most optimistic Hera analyst has a price target of €4.80 per share, while the most pessimistic values it at €4.40. The narrow spread of estimates could suggest that the business' future is relatively easy to value, or thatthe analysts have a strong view on its prospects.

    Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. One thing that stands out from these estimates is that revenues are expected to keep falling until the end of 2026, roughly in line with the historical decline of 0.7% per annum over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to see their revenue grow 6.1% per year. So it's pretty clear that, while it does have declining revenues, the analysts also expect Hera to suffer worse than the wider industry.

    The Bottom Line

    The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

    With that in mind, we wouldn't be too quick to come to a conclusion on Hera. Long-term earnings power is much more important than next year's profits. At Simply Wall St, we have a full range of analyst estimates for Hera going out to 2028, and you can see them free on our platform here..

    That said, it's still necessary to consider the ever-present spectre of investment risk. We've identified 2 warning signs with Hera , and understanding them should be part of your investment process.